Molecular determination of surgical margins using fossa biopsies at radical prostatectomy

Journal of Urology

Volumn 161, Issue 5, 1999, Pages 1442-1448

  Theodorescu, Dan ^a   Frierson Jr , Henry F ^a   Sikes, Robert A ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adenocarcinoma; Polymerase chain reaction; Prostate; Prostatic neoplasms; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0032881078     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68919-7     Document Type: Article

References (30)

1. Hermann, R. E. and Steiger, E.: Modified radical mastectomy. Surg. Clin. N. Amer., 58: 743, 1978.
2. Foster, R. S., Jr.: Surgery and radiotherapy for primary breast cancer. What we have learned from the controlled clinical trials. Surg. Clin. N. Amer., 64: 1125, 1984.
3. Epstein, J. I.: Incidence and significance of positive margins in radical prostatectomy specimens. Urol. Clin. N. Amer., 23: 651, 1996.
4. Humphrey, P. A. and Walther, P. J.: Adenocarcinoma of the prostate. I. Tissue sampling considerations. Amer. J. Clin. Path., 99: 746, 1993.
5. Sakr, W. A., Wheeler, T. M., Blute, M., Bodo, M., Calle-Rodrigue, R., Henson, D. E., Mostofi, F. K., Seiffert, J., Wojno, K. and Zincke, H.: Staging and reporting of prostate cancer - sampling of the radical prostatectomy specimen. Cancer, 78: 366, 1996.
6. Grignon, D. J. and Sakr, W. A.: Pathologic staging of prostate carcinoma. What are the issues? Cancer, 78: 337, 1996.
7. Eschwege, P., Dumas, F., Blanchet, P., Le Maire, V., Benoit, G., Jardin, A., Lacour, B. and Loric, S.: Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet, 346: 1528, 1995.
8. Sato, N., Gleave, M. E., Bruchovsky, N., Rennie, P. S., Beraldi, E. and Sullivan, L. D.: A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res., 57: 1584, 1997.
9. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
10. Sikes, R. A. and Chung, L. W.: Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res., 52: 3174, 1992.
11. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T. and Wise, G. J.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
12. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Samadi, D. S., Powell, C. T., Heston, W. D., Wise, G. J. and Fair, W. R.: Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J. Urol., 153: 573, 1995.
13. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R. and Heston, W. D.: Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807, 1994.
14. Hall, G. S., Kramer, C. E. and Epstein, J. I.: Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Amer. J. Surg. Path., 16: 315, 1992.
15. Chung, L. W., Chang, S. M., Bell, C., Zhau, H. E., Ro, J. Y. and von Eschenbach, A. C.: Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int. J. Cancer, 43: 1179, 1989.
16. Epstein, J. I. and Sauvageot, J.: Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression? J. Urol., 157: 241, 1997.
17. Alsikafi, N. F. and Brendler, C. B.: Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J. Urol., 159: 1281, 1998.
18. Stephenson, R. A., Middleton, R. G. and Abbott, T. M.: Wide excision (nonnerve sparing) radical retropubic prostatectomy using an initial perirectal dissection. J. Urol., 157: 251, 1997.
19. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.
20. Moreno, J. G., Shenot, P. J., Shupp-Byrne, D. and Gomella, L. G.: Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen. Tech. Urol., 2: 54, 1996.
21. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C. and Katz, A. E.: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373, 1995.
22. Ghossein, R. A., Rosai, J., Scher, H. I., Seiden, M., Zhang, Z. F., Sun, M., Chang, G., Berlane, K., Krithivas, K. and Kantoff, P. W.: Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology, 50: 100, 1997.
23. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G. and DeWolf, W.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
24. Grasso, Y. Z., Gupta, M. K., Levin, H. S., Zippe, C. D. and Klein, E. A.: Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res., 58: 1456, 1998.
25. Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Layton, T. J., Oswin, M. M., Lange, P. H. and Vessella, R. L.: Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin. Cancer Res., 3: 249, 1997.
26. Sokoloff, M. H., Tso, C.-L., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., deKernion, J. and Belldegrun, A.: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156: 1560, 1996.
27. Abbas, F. and Scardino, P. T.: Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol. Clin. N. Amer., 23: 587, 1996.
28. Edelstein, R. A., Zietman, A. L., de las Morenas, A., Krane, R. J., Babayan, R. K., Dallow, K. C., Traish, A. and Moreland, R. B.: Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47: 370, 1996.
29. Witjes, W. P., Schulman, C. C. and Debruyne, F. M.: Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. European Study Group on Neoadjuvant Treatment of Prostate Cancer. Urology, suppl., 49: 65, 1997.
30. Wright, G. L., Jr., Grob, B. M., Haley, C., Grossman, K., Newhall, K., Petrylak, D., Troyer, J., Konchuba, A., Schellhammer, P. F. and Moriarty, R.: Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology, 48: 326, 1996.